Early post-stress pulmonary uptake of 99mtc tetrofosmin during exercise (spect) myocardial perfusion imaging: correlation with haemodynamic, perfusion and function parameters

Nuclear Medicine Communications

Volumn 27, Issue 2, 2006, Pages 119-126

  Georgoulias, Panagiotis ^a   Demakopoulos, Nikolaos ^b   Kontos, Angelos ^b   Xaplanteris, Petros ^b   Xydis, Kostis ^b   Fezoylidis, Ioannis ^b  

^a UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^b NIMTS HOSPITAL   (Greece)

Author keywords

Lung heart ratio; Technetium 99m tetrofosmin

Indexed keywords

TETROFOSMIN TC 99M; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG UPTAKE; EXERCISE TEST; FEMALE; GATED IMAGING; HEART FUNCTION TEST; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEMODYNAMICS; HUMAN; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY BLOOD VESSEL; HEART; HEART MUSCLE; LUNG; METABOLISM; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STATISTICS;

AGED; AGED, 80 AND OVER; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; EXERCISE TEST; FEMALE; HEART; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LUNG; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS;

EID: 33645224629     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000194396.20067.ff     Document Type: Article

References (35)

1. Kurata C, Tawarahara K, Taguchi T, Sakata K, Yamazaki N, Naitoh Y. Lung thallium-201 uptake during exercise emission computed tomography. J Nucl Med 1991; 32:417-423.
2. Gill JB, Ruddy TD, Newell JB, Finkelstein DM, Strauss HW, Boucher CA. Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. N Engl J Med 1987; 317:1486-1489.
3. Mahmood S, Buscombe JR, Ell PJ. The use of thallium-201 lung/heart ratios. Eur J Nucl Med 1992; 19:807-814.
4. Hurwitz GA, O'Donoghue JP, Powe JE, Gravelle DR, MacDonald AC, Finnie KJC. Pulmonary thallium-201 uptake following dipyridamole-exercise combination compared with single modality stress-testing. Am J Cardiol 1992; 69:320-326.
5. Kaul S, Finkelstein DM, Homma S, Leavitt M, Okada RD, Boucher CA. Superiority of quantitative exercise thallium-201 variables in determining long-term prognosis in ambulatory patients with chest pain: a comparison with cardiac catheterization. J Am Coll Cardiol 1998; 12:25-34.
6. Liu P, Kiess M, Okada RD, Strauss HW, Block PC, Pohost GM, et al. Increased thallium lung uptake after exercise in isolated left anterior descending coronary artery disease. Am J Cardiol 1985; 55:1469-1473.
7. Homma S, Kaul S, Boucher CA. Correlates of lung/heart ratio of thallium-201 in coronary artery disease. J Nucl Med 1987; 28:1531-1535.
8. Hurwitz GA, Ghali SK, Husni M, Slomka PJ, Mattar AG, Reid RH, et al. Pulmonary uptake of technetium-99m-sestamibi induced by dipyridamole based stress or exercise. J Nucl Med 1998; 39:339-345.
9. Giubbini R, Campini R, Milan E, Zoccarato O, Orlandi C, Rossini P, et al. Evaluation of technetium-99m-sestamibi lung uptake: correlation with left ventricular function. J Nucl Med 1995; 36:58-63.
10. Saha M, Farrand TF, Brown KA. Lung uptake of technetium 99m sestamibi: relation to clinical, exercise, hemodynamic and left ventricular function variables. J Nucl Cardiol 1994; 1:52-56.
11. Hurwitz GA, Fox SP, Driedger AA, Willems C, Powe JE. Pulmonary uptake of sestamibi on early post-stress images: angiographic relationships, incidence and kinetics. Nucl Med Commun 1993; 14:15-22.
12. Choy JB, Leslie WD. Clinical correlates of Tc-99m sestamibi lung uptake. J Nucl Cardiol 2001; 8:639-644.
13. Patel GM, Hauser TH, Parker JA, Pinto DS, Sanders GP, Aepfelbacher FC, et al. Quantitative relationship of stress Tc-99m sestamibi lung uptake with resting TI-201 lung uptake and with indices of left ventricular dysfunction and coronary artery disease. J Nucl Cardiol 2004; 11:408-413.
14. 99mTc sestamibi: determinants, independence and significance of counts in lung, abdomen and myocardium. Nucl Med Commun 2000; 21:887-895.
15. 99mTc-sestamibi determined by a new automatic technique: validation and application in detection of severe and extensive coronary artery disease and reduced left ventricular function. J Nucl Med 2000; 41:1190-1197.
16. 99mTc-sestamibi lung/heart ratio, transient ischaemic dilation and perfusion defect size for the identification of severe and extensive coronary artery disease. Eur J Nucl Med 2001; 28:907-910.
17. Hurwitz GA, Blais M, Powe JE, Champagne CL. Stress/injection protocols for myocardial scintigraphy with Tc-99m sestamibi and thallium-201: implications of early post-stress kinetics. Nucl Med Commun 1996; 17:400-409.
18. Tsou SS, Sun SS, Kao A, Lin CC, Lee CC. Exercise and rest technetium-99m-tetrofosmin lung uptake: correlation with left ventricular ejection fraction in patients with coronary artery disease. Jpn Heart J 2002; 43:515-522.
19. 99mTc-tetrofosmin uptake measurement by the exercise myocardial scintigraphy in patients with ischemic heart disease. Kaku Igaku 1998; 35:189-195.
20. Okajima T, Ueshima K, Nishiyama O, Ogawa M, Ohuchi M, Saitoh M, et al. Relationship between lung-to-heart uptake ratio of technetium-99m-tetrofosmin during exercise myocardial single photon emission computed tomographic imaging and the number of diseased coronary arteries in patients with effort angina pectoris without myocardial infarction. J Cardiol 2004; 43:165-171.
21. m-tetrofosmin lung uptake: A modified method to avoid the contribution from high chest wall activity. Nucl Med Commun 1998; 19:859-866.
22. Heo J, Cave V, Wasserleben V, Iskandrian A. Planar and tomographic imaging with technetium 99m-labeled tetrofosmin: Correlation with thallium-201 and coronary angiography. J Nucl Cardiol 1994; 1:17-24.
23. 99mTc-tetrofosmin myocardial perfusion imaging: a comparison with coronary angiography. Nuklearmedizin 1996; 35:153-155.
24. Nakajima K, Taki J, Shuke N, Bunko H, Takata S, Hisada K. Myocardial perfusion imaging and dynamic analysis with technetium-99m tetrofosmin. J Nucl Med 1993; 34:1478-1484.
25. Sridhara BS, Braat S, Rigo P, Itti R, Cload P, Lahiri A. Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease. Am J Cardiol 1993; 72:1015-1019.
26. Flamen P, Bossuyt A, Franken R. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: Intraindividual comparison with technetium-99m-sestamibi. J Nucl Med 1995; 36:2009-2015.
27. Schinkel AFL, Elhendy A, Van Domburg RT, Bax JJ, Vourvouri EC, Bountioukos M, et al. Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac events. Am J Cardiol 2003; 91:408-411.
28. m-MIBI cardiac SPECT interpretation. Nucl Med Commun 1996; 17:851-856.
29. Desai MY, De La Pena-Almaguer E, Mannting F. Abnormal heart rate recovery after exercise: a comparison with known indicators of increased mortality. Cardiology 2001; 96:38-44.
30. Fletcher GF, Balady G, Froelicher VF, Hartley LH, Haskell WL, Pollock ML. Exercise standards. A statement for healthcare professionals from the American Heart Association Writing Group. Circulation 1995; 91:580-615.
31. Hesse B, Tägil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med 2005; 32:855-897.
32. Cerquira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. J Nucl Med 2002; 9:240-245.
33. Kapur A, Latus KA, Davies G, Dhawan RT, Eastick S, Jarrit PH, et al. A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study. Eur J Nucl Med 2002; 29:1608-1616.
34. Glantz AS. Primer of Biostatistics, 5th edition. New York: McGraw Hill; 2002.
35. Munch G, Neverve J, Matsunari I, Schöter G, Schwaiger M. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease. J Nucl Med 1997; 38:428-432.